Skip to content

Rapid Micro Biosystems RPID Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$174.8M+4.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$439.87M-5.9%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$113.4M+12.7%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$1.4M-19.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$7.94M+52.0%
WAT
Waters CorporationWAT
$355M

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's operating lease liabilities (total)?
Rapid Micro Biosystems (RPID) reported operating lease liabilities (total) of $4.48M in Q1 2026.
How has Rapid Micro Biosystems's operating lease liabilities (total) changed year-over-year?
Rapid Micro Biosystems's operating lease liabilities (total) decreased by 20.9% year-over-year, from $5.67M to $4.48M.
What is the long-term trend for Rapid Micro Biosystems's operating lease liabilities (total)?
Over 3 years (2022 to 2025), Rapid Micro Biosystems's operating lease liabilities (total) has grown at a -14.4% compound annual growth rate (CAGR), from $7.63M to $4.79M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.